EP2451816A4 - Kristallinform aus prasugrel-hydrobromid, herstellung und anwendung davon - Google Patents

Kristallinform aus prasugrel-hydrobromid, herstellung und anwendung davon

Info

Publication number
EP2451816A4
EP2451816A4 EP10796816A EP10796816A EP2451816A4 EP 2451816 A4 EP2451816 A4 EP 2451816A4 EP 10796816 A EP10796816 A EP 10796816A EP 10796816 A EP10796816 A EP 10796816A EP 2451816 A4 EP2451816 A4 EP 2451816A4
Authority
EP
European Patent Office
Prior art keywords
preparation
application
crystalline form
prasugrel hydrobromide
prasugrel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP10796816A
Other languages
English (en)
French (fr)
Other versions
EP2451816A1 (de
Inventor
Srinivas Sanikommu Reddy
Shankar Sanganabhatla
Antyakula Pydi Bhaskar Rao
Mubeen Ahmed Khan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glenmark Generics Ltd
Original Assignee
Glenmark Generics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glenmark Generics Ltd filed Critical Glenmark Generics Ltd
Publication of EP2451816A1 publication Critical patent/EP2451816A1/de
Publication of EP2451816A4 publication Critical patent/EP2451816A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
EP10796816A 2009-07-06 2010-06-25 Kristallinform aus prasugrel-hydrobromid, herstellung und anwendung davon Withdrawn EP2451816A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1596MU2009 2009-07-06
PCT/IN2010/000435 WO2011004392A1 (en) 2009-07-06 2010-06-25 Crystalline form of prasugrel hydrobromide, preparation and application thereof

Publications (2)

Publication Number Publication Date
EP2451816A1 EP2451816A1 (de) 2012-05-16
EP2451816A4 true EP2451816A4 (de) 2013-02-27

Family

ID=43428854

Family Applications (1)

Application Number Title Priority Date Filing Date
EP10796816A Withdrawn EP2451816A4 (de) 2009-07-06 2010-06-25 Kristallinform aus prasugrel-hydrobromid, herstellung und anwendung davon

Country Status (2)

Country Link
EP (1) EP2451816A4 (de)
WO (1) WO2011004392A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2398468T1 (sl) 2009-02-17 2017-03-31 Krka, D.D., Novo Mesto Farmacevtske sestave, ki obsegajo prasugrel ali njegove farmacevtsko sprejemljive kislinske adicijske soli in postopek za njihovo pripravo
JP5501438B2 (ja) * 2009-03-31 2014-05-21 上海医薬工業研究院 プラスグレル臭化水素酸塩の結晶
EP2360159A1 (de) * 2010-02-11 2011-08-24 Ratiopharm GmbH Prasugrel in mikronisierter, kristalliner Form und pharmazeutische Zusammensetzung davon
CN102656175B (zh) * 2010-04-08 2015-08-26 特瓦制药工业有限公司 普拉格雷盐的晶形
CZ305314B6 (cs) * 2010-12-30 2015-07-29 Zentiva, K.S. Nový hydrobromid formy C 5-[2-cyklopropyl-1-(2-fluorofenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetátu známého pod nechráněným názvem prasugrel a způsob jeho výroby
CN102746318A (zh) * 2011-04-20 2012-10-24 上海信谊药厂有限公司 用于制备普拉格雷盐酸盐的方法
CN103102356B (zh) * 2011-11-11 2016-01-27 山东新时代药业有限公司 一种氢溴酸普拉格雷的制备方法
CZ2011872A3 (cs) * 2011-12-22 2013-07-03 Zentiva, K.S. Farmaceutická formulace prasugrelu hydrobromidu
US8603537B2 (en) 2012-04-02 2013-12-10 Egis Pharmaceuticals Plc Prasugrel containing quickly released stable oral pharmaceutical compositions
CN103012427B (zh) * 2012-11-26 2015-07-08 天津大学 一种普拉格雷盐酸盐乙醇溶剂化物及其制备方法
CN103232446B (zh) * 2013-05-17 2015-09-23 天津药物研究院 一种噁唑烷酮衍生物晶型ⅱ及其制备方法和用途
WO2016203018A1 (en) 2015-06-19 2016-12-22 Sanovel Ilac Sanayi Ve Ticaret A.S. Pharmaceutical compositions of prasugrel hydrobromide

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011057593A2 (en) * 2009-11-16 2011-05-19 Zentiva, K.S. New salts of prasugrel and a method of their production

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2415558C (en) * 2000-07-06 2010-09-14 Sankyo Company, Limited Acid addition salts of hydropyridine derivatives
TWI392681B (zh) * 2006-04-06 2013-04-11 Daiichi Sankyo Co Ltd 高純度普拉格雷及其酸加成鹽之製法
CN101255169B (zh) * 2008-03-26 2010-11-10 山东大学 普拉格雷盐及其制备方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011057593A2 (en) * 2009-11-16 2011-05-19 Zentiva, K.S. New salts of prasugrel and a method of their production

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2011004392A1 *

Also Published As

Publication number Publication date
EP2451816A1 (de) 2012-05-16
WO2011004392A1 (en) 2011-01-13

Similar Documents

Publication Publication Date Title
EP2451816A4 (de) Kristallinform aus prasugrel-hydrobromid, herstellung und anwendung davon
HK1250313A1 (zh) 穩定的藥物組合物和使用所述組合物的方法
HK1164050A1 (en) Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof
EP2477628A4 (de) Herstellung kristalliner formen von dihydropyrazolopyrimidinon
AP3049A (en) New crystalline form VI of agomelatine, preparation method and application thereof
EP2364312A4 (de) Herstellung von kristallinem palonosetron-hydrochlorid
HK1165802A1 (en) Derivatives of benzothiazines, preparation thereof and application thereof as drugs
PL3210991T3 (pl) Postać krystaliczna lewoizowalerylospiramycyny II oraz preparaty, sposoby wytwarzania i ich zastosowanie
EP2516404A4 (de) Herstellung von bendamustin und dessen salzen
EP2470542A4 (de) Herstellung von sitagliptin und salzen davon
IL247929B (en) Stable compositions of 595–sns and methods for their preparation
EP2497766A4 (de) Kristalline form von bimatoprost sowie herstellungsverfahren dafür und verwendung davon
EP2490541A4 (de) 2-substituierte ethynylthiazolderivate und ihre verwendung
EP2601200A4 (de) Präparat aus prasugrelhydrochlorid
GB201210536D0 (en) Composition, use and method of preparation thereof
EP2452681A4 (de) Salze von 13a-(s-)desoxytylphorinin, verfahren zu ihrer herstellung sowie pharmazeutische zusammensetzungen daraus und verwendungen davon
PL2513099T3 (pl) Wytwarzanie związków n-monofluoroalkilowych
IL215512A0 (en) Substituted 1-alkylcinnolin-4(1h)-one derivatives, preparation thereof and therapeutic application of same
GB201301307D0 (en) Crystalline form of prulifloxacin and processes for its preparation
EP2459540A4 (de) Herstellung von fipamezol
GB201002278D0 (en) composition and method of preparation

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20120201

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

TPAC Observations filed by third parties

Free format text: ORIGINAL CODE: EPIDOSNTIPA

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20130128

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 9/10 20060101ALI20130122BHEP

Ipc: C07D 495/04 20060101AFI20130122BHEP

Ipc: A61P 7/02 20060101ALI20130122BHEP

Ipc: A61K 31/4365 20060101ALI20130122BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20130827